BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10538848)

  • 1. An overview of cancer economics. Based on a presentation by C. Daniel Mullins, PhD.
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S371-6. PubMed ID: 10538848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
    Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
    Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of illness associated with metastatic breast cancer.
    Rao S; Kubisiak J; Gilden D
    Breast Cancer Res Treat; 2004 Jan; 83(1):25-32. PubMed ID: 14997052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of breast cancer: the global burden, public health considerations.
    Forbes JF
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-20-S1-35. PubMed ID: 9045313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer.
    Suh WW; Pierce LJ; Vicini FA; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):790-6. PubMed ID: 15936561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of prostate cancer, California, 1998.
    Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
    Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
    Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting the economic literature in oncology.
    Grusenmeyer PA; Wong YN
    J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.